Amy Fan

Ph.D. Student in Immunology, admitted Autumn 2016 Senior Program Leader, EPS - Diversity, Equity & Inclusion

Bio

Amy Fan is an Immunology PhD candidate in Dr. Ravi Majeti's lab, with research interests in immunology, stem cell biology, and cancer. Her thesis work investigates the mechanism of blood cancer progression in patients with inherited mutations in the RUNX1 gene. Prior to joining Stanford in 2016, she earned her B.S. in Biology from MIT and worked for two years at the Broad Institute of MIT & Harvard. Outside of lab, she devotes time to teaching, mentoring, and diversity advocacy, and she likes to relax by dancing, hiking, and painting.

Honors & Awards

Amgen Scholar, Amgen Foundation (Jun - Aug 2014)
Gene Brown Prize for Teaching, MIT Department of Biology (June 2015)
Stanford Graduate Fellowship, Stanford University (September 2016)
NSF Graduate Research Fellowship, National Science Foundation (March 2017)
Stanford Biosciences Travel Grant, Stanford Biosciences (Aug 2018)
Excellence in Advocacy, Stanford Diversity & Advocacy Committee (May 2019)
Community Impact Award, Stanford Alumni Association (May 2019)
Excellence in Service to Grad Students, Stanford Biosciences (June 2019)
Best Graduate Student Talk, Stanford Immunology (November 2020)
ASH Abstract Achievement Award, American Society of Hematology (November 2020)
Gerald J. Lieberman Fellowship, Stanford University (May 2021)
James W. Lyons Award, Stanford University (May 2021)
Experimental Hematology Travel Grant, ISEH (August 2021)

Boards, Advisory Committees, Professional Organizations

Member, International Society of Experimental Hematology (2018 - Present)

Membership Organizations

<a href="https://www.bioaims.com/">Biomedical Association for the Interest of Minority Students (BioAIMS)</a>, President

Professional Education

BS, Massachusetts Institute of Technology, Biology (2015)

Current Research and Scholarly Interests

Germline mutations in RUNX1 cause an autosomal dominant disorder characterized by lifelong thrombocytopenia and increased risk of progression to acute myeloid leukemia (AML). Indeed, unlike sporadic AML, which commonly presents in the elderly, the average age of onset for RUNX1 familial AML cases is 35, with over one-third of patients developing leukemia as a child. While megakaryocyte defects have been shown to be a cell-autonomous effect of RUNX1 mutations in hematopoietic stem and progenitor cells (HSPCs), the mechanisms by which germline RUNX1 mutations progress to leukemia remains unclear. Interestingly, RUNX1 is also expressed in bone marrow mesenchymal stromal cells (BM-MSCs), which have been shown to contribute to the pathogenesis of some hematopoietic malignancies. The goal of my thesis research is to determine how RUNX1 mutations may be contributing to leukemogenesis through both cell autonomous and non-autonomous mechanisms.

Lab Affiliations

Ravindra Majeti, (6/1/2017)

All Publications

Profiles With Related Publications

close
Xiangqi Bai

Postdoctoral Scholar, Oncology

5 Total Publications
close
Tyler Chen

Ph.D. Student in Bioengineering, admitted Autumn 2019

2 Total Publications
close
Steven M. Corsello

Assistant Professor of Medicine (Oncology) and, by courtesy, of Chemical and Systems Biology
Clinical Focus
Medical Oncology

24 Total Publications
close
Oana M. Enache

Ph.D. Student in Biomedical Informatics, admitted Autumn 2021

10 Total Publications
close
Nathanael S. Gray

Krishnan-Shah Family Professor

68 Total Publications
close
Rodrigo Guarischi Sousa

Postdoctoral Scholar, Cardiovascular Medicine
Research Interests
Absolutely passionate about bioinformatics and biological questions that can be addressed by DNA sequencing, especially ideas that may be applied to improve general public health.

5 Total Publications
close
Brian Hie

Postdoctoral Scholar, Biochemistry

13 Total Publications
close
Daniel Hoces Burga

Postdoctoral Scholar, Bioengineering

10 Total Publications
close
Livnat Jerby

Assistant Professor of Genetics
Research Interests
Immune responses are highly orchestrated processes that span various interconnected regulatory modalities within and across cells. My lab develops high-throughput, quantitative, engineering-based, approaches to dissect multicellular immune dynamics at unprecedented scale, resolution, and depth, and identify new immunomodulating interventions at an accelerated pace.

25 Total Publications
close
YoungJu Jo

Ph.D. Student in Applied Physics, admitted Autumn 2018

22 Total Publications
close
Joseph Knoedler

Basic Life Res Scientist, Psych/Major Laboratories and Clinical & Translational Neurosciences Incubator

1 Total Publications
close
Caleb Lareau

Instructor, Pathology

79 Total Publications